Citation:
I. Glenn Cohen and Shelly Simana. 2018. “Regulation of Stem Cell Travel.” Current Stem Cell Reports, 4, Pp. 220–227. Publisher's Version
Abstract:
A new regulatory framework aimed at reducing the risks associated with SCT travel and the provision of unproven SCT should be implemented. It should include professional guidelines, an accreditation system that would evaluate SCT being offered by clinics, enforcement mechanisms against fraud, reimbursement by insurers for approved SCT, and residency requirements.